Clinical Trials

10 enrolled

Adenocarcinoma of Lung

NCT05794724 2023-07-24

Intraoperative Frozen Section Pathology to Guide Surgical Treatment for Lung Adenocarcinoma (ECTOP-1016)

1,063 enrolled

Adenocarcinoma of Lung

NCT03380468 2023-07-20

ECTOP-1004

Phase 2/3 Unknown

Adenocarcinoma of Lung, Lung Neoplasms

NCT05907577 2023-06-18

Early Detection of Lung Cancer With Machine Learning Based on Routine Clinical Investigations

7,500 enrolled

Adenocarcinoma of Lung, Bronchial Neoplasms

NCT05527808 2023-06-08

A Single-arm Exploratory Study of Neoadjuvant Therapy

28 enrolled

Adenocarcinoma of Lung

NCT05736991 2023-02-21

Deep Learning Signature for Predicting the Novel Grading System of Clinical Stage I Lung Adenocarcinoma

600 enrolled

Adenocarcinoma of Lung

NCT04459078 2022-12-02

Clinical Study of Camrelizumab Combined With APatinib and Albumin Paclitacxel in Patients With Advanced Lung Adenocarcinoma

63 enrolled

Adenocarcinoma of Lung

NCT05565677 2022-10-04

LungCaMa3D

50 enrolled

Adenocarcinoma of Lung, Lung Neoplasms

NCT04122833 2022-08-18

Impact of Concomitant Genetic Alterations in EGFR Mutated Adenocarcinoma by NGS Analysis: A Multicenter Study

80 enrolled

Adenocarcinoma of Lung

NCT05400304 2022-06-29

Radiomics Combined With Frozen Section Prediction Model for Spread Through Air Space in Lung Adenocarcinoma

900 enrolled

Adenocarcinoma of Lung

NCT05395611 2022-05-27

Exhaled Breath Particles in Lung Cancer

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05279521 2022-03-15

The Effect of Interventional Pulmonary Rehabilitation Exercise With Advanced Lung Cancer.

104 enrolled

Adenocarcinoma of Lung, Lung Neoplasms, Motor Activity

NCT05228795 2022-02-08

Glypican-1 Expression in Epithelioid Mesothelioma, Adenocarcinoma and SCC of the Lung

Other solid neoplasmThoracic

60 enrolled

Adenocarcinoma of Lung, Mesothelioma

NCT05136014 2021-11-26

OS-TUMOVASC

200 enrolled

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05079022 2021-10-15

ctDNA-MRD Based Adjuvant Targeted Therapy for EGFR Positive Stage I Lung Adenocarcinomas

Phase 1/2 Unknown

50 enrolled

Adenocarcinoma of Lung, Neoplasm, Residual

NCT05010330 2021-08-18

Identify Prognostic Biomarkers of Lung Cancer

500 enrolled

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03298763 2021-04-28

TACTICAL

Phase 1/2 Unknown

46 enrolled

Adenocarcinoma of Lung

NCT04692935 2021-01-05

Comparative Genomic Profiling of Lung Adenocarcinoma in Asians and Caucasians: A Propensity Matched Analysis

450 enrolled

Adenocarcinoma of Lung

NCT03254004 2020-12-14

Postoperative Pembrolizumab for the Patients Who Have Solid Predominant or Micropapillary Lung Adenocarcinoma With Pathologic Stage I and Primary Tumor Than 4 cm

70 enrolled

Adenocarcinoma of Lung

NCT04554875 2020-09-18

Derivation and Validation of a Scoring System to Distinguish Cryptococcosis and Adenocarcinoma in Pulmonary Nodules

1,000 enrolled

Adenocarcinoma of Lung, Cryptococcosis

NCT04482829 2020-07-23

TCM in the Treatment of Lung Adenocarcinoma

144 enrolled

Adenocarcinoma of Lung

NCT03905317 2019-04-05

Bevacizumab and Radiotherapy for Oligometastasis of Lung Adenocarcinoma With Negative Driver Gene

66 enrolled

Adenocarcinoma of Lung

NCT03090815 2017-03-27

Circulating Tumor DNA (ctDNA) as a Prognostic Tool in Patients With Advanced Lung Adenocarcinoma

Adenocarcinoma of Lung

NCT02282267 2017-02-24

Benefit

188 enrolled

Adenocarcinoma of Lung

NCT02787447 2016-11-25

Radiotherapy Combined With Thymosin for Metastatic NSCLC Patients Who Showed Stable Disease After First Line TKI Therapy

46 enrolled

Adenocarcinoma of Lung

NCT02951897 2016-11-02

CTCs detection

120 enrolled

Adenocarcinoma of Lung, Disease, Neoplastic Cells, Circulating

NCT02951637 2016-11-01

Chemotherapy Plus Gefitinib for Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Controlled Trial

Adenocarcinoma of Lung, Adenocarcinoma

NCT02946216 2016-10-27

ALK/ROS1/MET Mutations on Plasma ctDNA in Patients With NSCLC

200 enrolled

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

NCT02898857 2016-09-13

NOTCH

18 enrolled

Adenocarcinoma of Lung

NCT02843711 2016-07-26

LUNG-EST

152 enrolled

Adenocarcinoma of Lung

NCT02788058 2016-06-02

A Study of Hypofractionated Radiotherapy for Limited Metastatic NSCLC Harboring Sensitizing EGFR Mutations After First Line TKI Therapy

76 enrolled

Adenocarcinoma of Lung

NCT02738684 2016-04-14

A Study to Predict Gefitinib' s Efficacy for Lung Cancer by Plasma Free Nucleic Acids EGFR Gene Mutation Test

Adenocarcinoma of Lung, Adenocarcinoma, Lung Neoplasms

NCT02691871 2016-02-25

Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Lung Adenocarcinoma Harboring Wild-type EGFR

Phase 1 Unknown

20 enrolled

Adenocarcinoma of Lung

NCT02132143 2015-05-06

Comparative Study of Chemoradiation and Sequential Chemoradiation About Lung Adenocarcinoma Patients With Postoperative in pN2

60 enrolled

Adenocarcinoma of Lung

NCT02399566 2015-03-26

Clinical Trial of Erlotinib and Pemetrexed for Maintenance Treatment in Lung Adenocarcinoma

Phase 4 Unknown

Adenocarcinoma of Lung

NCT02288026 2014-11-11

Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer

630 enrolled

Adenocarcinoma of Lung, Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02239432 2014-09-12

Telomere Biology in Early Adenocarcinoma of the Lung

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar

NCT02011997 2013-12-16

cVATS

Phase 3 Unknown

500 enrolled

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

NCT01942629 2013-09-16

Prognostic Value of the Marker P63 in Adenocarcinoma of Lung, Breast, and Pancreas

Adenocarcinoma of Lung

NCT01482585 2011-11-30

Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy

200 enrolled

Adenocarcinoma of Lung

NCT00260871 2011-07-29

Genetic Epidemiological Study of Lung Cancer in Taiwan and Clinical Applications

1,500 enrolled

Adenocarcinoma of Lung, Lung Neoplasms

NCT01249053 2010-11-29

Expression of Optic Atrophy Type 1 (OPA1) Protein in Lung Adenocarcinoma

Adenocarcinoma of Lung

NCT01249066 2010-11-29

Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma